Feb 2, 2021
John Curtis- Amount
- Receipt pending ingestion
- Filed
- Feb 4, 2021
Congress ticker disclosure profile
As of August 1 at 7:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference DOMO. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
3
Disclosed ranges
$106K
Most active member desks
Balanced
Latest trade Feb 2, 2021
Feb 2, 2021
John CurtisDec 23, 2019
John CurtisAug 2, 2019
John CurtisJun 24, 2019
Donna ShalalaApr 29, 2019
John CurtisMar 20, 2019
Tom MalinowskiMar 19, 2019
Donna ShalalaMar 18, 2019
Tom MalinowskiMar 6, 2019
Tom MalinowskiMar 4, 2019
Tom Malinowski| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Feb 2, 2021 | John Curtis | Sell | Receipt pending ingestion | Feb 4, 2021 | Receipt pending ingestion |
| Dec 23, 2019 | John Curtis | Sell | Receipt pending ingestion | Apr 9, 2020 | Receipt pending ingestion |
| Aug 2, 2019 | John Curtis | Buy | Receipt pending ingestion | Apr 9, 2020 | Receipt pending ingestion |
| Jun 24, 2019 | Donna Shalala | Sell | Receipt pending ingestion | Apr 27, 2020 | Open card |
| Apr 29, 2019 | John Curtis | Buy | Receipt pending ingestion | Apr 9, 2020 | Receipt pending ingestion |
| Mar 20, 2019 | Tom Malinowski | Buy | $15,001 to $50,000 | Aug 26, 2021 | Open card |
| Mar 19, 2019 | Donna Shalala | Buy | Receipt pending ingestion | Apr 27, 2020 | Open card |
| Mar 18, 2019 | Tom Malinowski | Sell | $15,001 to $50,000 | Jul 9, 2021 | Open card |
| Mar 6, 2019 | Tom Malinowski | Buy | $15,001 to $50,000 | Aug 26, 2021 | Open card |
| Mar 4, 2019 | Tom Malinowski | Sell | $1,001 to $15,000 | Jul 9, 2021 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 4 of 10 filed rows include disclosed amount ranges (40%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.